Four days ago, The Guardian reported that there was “excitement among patients and researchers” in the UK as “personalized mRNA vaccines” for cancer entered their phase 3 trial. On Monday, In Your Area published an article about a personalized mRNA skin cancer vaccine that may also be effective against lung, bladder, and kidney cancer.